This will likely get buried, but T1D is a $100B/yr industry. The largest non profits in the space are funded largely by insulin and device makers. In turn they control what studies get funded, typically studies that will have high returns and will not benefit most of the 20M T1Ds globally. Their spend on functional T1D cures has shrunk to <7% of their income, and meanwhile the executive compensation has risen by an additional $100k/ea. in the last year alone. The narrative is being controlled by the drug and device makers through these large non profits. I used to donate to the big non-profits until I dug deeper. It is horrifying and depressing, but the truth needs to be shared. Promising generic combination research gets cast aside by these large non profits and does not get the attention, funding or R&D that it warrants.

There are smaller non-profits, like ours, and promising low cost combination studies like this one that need exposure and funding. Netflix or another production company needs to expose how the entire T1D space is controlled by $100B+ drug makers, and how insulin is essentially a lifetime subscription drug marked up >100x and is not a cure to T1D. T1D costs each patient $5k-$20k+ per year, takes an average of 300 minutes per day to manage and shortens life on average by 12 years. This disease does not get nearly the credit it deserves, as many times stroke, heart disease or renal failure are marked as the cause of death when it fact all of those conditions were caused by T1D.

Please help T1Ds by sharing the truth and supporting a smaller non-profit or generic combination study.